Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FDB8P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,512
Award facts
- Contract value 100% obligated
- $28,512.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,512.18 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on January 27, 2026, with an ultimate completion date of January 28, 2026. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and is being fulfilled from the company's Conshohocken, Pennsylvania location. The award represents a task order executed under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, serving as the primary vehicle for delivering pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen operates as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent entity, Cencora, Inc., maintains a comprehensive portfolio of pharmaceutical distribution capabilities covering specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains. Zepbound, a diabetes management medication, aligns with the company's demonstrated experience supplying endocrinology products through its federal contract portfolio, reinforcing its established capability to meet Department of Defense healthcare requirements through open and full competition.
Quick answers
Who was awarded contract SPE2DR26FDB8P?
SPE2DR26FDB8P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FDB8P worth?
The government has obligated $28,512 on SPE2DR26FDB8P.
Is contract SPE2DR26FDB8P an order under another contract?
Yes. SPE2DR26FDB8P is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDB8P competed?
The extent of competition for SPE2DR26FDB8P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award